As the Rolling Stones famously said, please allow me to introduce myself. I’m Jason Lomberg, Pharmaceutical Processing’s new Editor. I come to you courtesy of Pharm Pro’s sister pub, Electronic Component News....
Dr. Cooper brings extensive experience in pioneering the development of adoptive cellular...
Patients that actively sought clinical trial participation through an industry leader...
PhRMA honored 13 employees from 12 biopharmaceutical companies as “We Work For Health Champions” for their extraordinary efforts in policy advocacy and community service.
A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."
Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its current EVP and Chief Legal Officer Michael Logerfo has been appointed President.
Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.
The number of people who have enrolled for their 2015 employee benefits doubled in the last year from 3 million to 6 million people.
Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed.
DelMar Pharmaceuticals, Inc., today announced that it has appointed biopharmaceutical industry veteran, Erich Mohr, Ph.D., R.Psych., to its Board of Directors as an independent director.
Ipsen announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A., responsible for all commercial and medical affairs operations throughout the region.
Bacterin International Holdings, Inc. is pleased to announce the addition of Jimmy Bornheimer, Vice President of Finance, and Stephen Smith, Vice President of Regulatory and Quality Assurance.
Bio-Path Holdings, Inc., announced that Dr. Ulrich W. Mueller has joined the Company as Chief Operating Officer.
LifeScience Alley announced today that Dale Wahlstrom has elected to retire from LifeScience Alley and The BioBusiness Alliance of Minnesota, effective August 15, 2014, but will step down as president and CEO on May 1, providing support to the leadership transition and completing several strategic initiatives currently underway.
Simulations Plus, Inc., today announced that Ms. Momoko Beran has notified the board of directors of her plan to retire effective as of January 15, 2014.
Metrics Inc. has appointed Joe Cascone as senior director of operations. In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related operations such as engineering, environmental health and safety, and security.
Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company's senior director of parenteral operations for its manufacturing facility in Charleston, S.C.
Tau Therapeutics LLC announced two key hires for its executive management team. Bruce A. Silver, MD, FACP, as Chief Medical Officer will lead Tau’s clinical development and research program centered on mibefradil and its novel Interlaced Therapy™ approach. Paul H. Sartori, PhD, MBA, will fill the new position of Vice President of Operations and Strategy.
Bristol-Myers Squibb Appoints Mike Burgess M.D., Ph.D. Senior Vice President, Discovery Medicine and Clinical PharmacologyJanuary 18, 2013 2:56 am | News | Comments
Bristol-Myers Squibb Company announced that Mike Burgess M.D., Ph.D. has joined the Company as senior vice president, Discovery Medicine and Clinical Pharmacology.
Norwich Pharmaceuticals has announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development and technical services (PDTS).
The new, expanded membership of AstraZeneca’s Senior Executive Team, which comes into effect immediately, includes increased representation of the company’s scientific expertise, key products and key markets.
AMRI has announced that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately.
Patheon Inc., a provider of contract development and manufacturing services to the global pharmaceutical industry, today announced, in connection with the close of the Banner acquisition, that Geoff Glass has been appointed president of the new proprietary products business unit.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
BEDMINSTER, N.J. (AP) — Amarin Corp. PLC says it has secured new financing and will hire sales staff to get its fish-oil drug to market.
AmerisourceBergen Names Peyton R. Howell as Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer RelationshipsDecember 5, 2012 2:53 am | News | Comments
AmerisourceBergen Corporation today announced that Peyton R. Howell has been named Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer Relations, effective immediately.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed David Browne as the company's director of analytical chemistry for its Edison, N.J. laboratory.
- Page 1